08/31/2026
Overactivation of the Endocannabinoid System is one of the most important metabolic conversations people still aren’t having. The ECS is supposed to help maintain balance, not just in mood and pain, but in appetite, energy storage, glucose metabolism, inflammation, fat signaling, liver function, and how the body decides whether to burn or store fuel.
That balance matters because anandamide and 2-AG don’t just work in the brain. They bind CB1 and CB2 receptors throughout the body, including metabolic tissues like the liver, pancreas, skeletal muscle, adipose tissue, and gut. When ECS tone is healthy, it helps regulate energy flow.
When the system becomes overactive, especially through excess endocannabinoid activity and CB1 receptor signaling, the body can be pushed toward more hunger, more fat storage, less energy expenditure, glucose intolerance, insulin resistance, fatty liver, and metabolic dysfunction.
This is why I always say ECS Balance is not just a cannabis topic. It’s a whole-body health topic.
Research has shown that obesity is associated with increased endocannabinoid activity in central and peripheral tissues, and that CB1 activation can influence food intake, lipid metabolism, glucose metabolism, adipose tissue expansion, and insulin sensitivity.
One review explained that animal models of obesity show elevated endocannabinoid tone. At the same time, CB1 blockade or genetic CB1 deletion can reduce adiposity and improve metabolic markers like insulin, glucose, leptin, triglycerides, and adiponectin. Another review focused on adipose tissue noted that obesity is associated with excess ECS activity in visceral fat, making CB1 signaling a major metabolic target.
The NPY research makes the story even more interesting. In mice with neuropeptide Y overexpression in noradrenergic neurons, researchers measured anandamide and 2-AG across metabolic tissues, including hypothalamus, pancreas, adipose tissue, liver, and muscle.
They found that anandamide levels increased in adipose tissue and pancreas at the same time these animals developed higher fat mass and impaired glucose tolerance. That suggests ECS overactivation can show up in the same tissues where metabolic disease is developing.
This is not about demonizing the ECS. It’s about respecting it enough to stop thinking more signaling is always better. Too little ECS tone can create its own problems, but too much CB1-driven activity can push metabolism in the wrong direction.
Balance is the key.
The ECS can help us heal, regulate, eat, sleep, calm pain, and feel alive, but when it’s overactivated, the same Master Regulator can become part of the metabolic storm.
Mike Robinson
Founder, Global Cannabinoid Research Center
The Researcher OG
Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
https://pubmed.ncbi.nlm.nih.gov/17720356/
The endocannabinoid system in the adipose organ
https://pmc.ncbi.nlm.nih.gov/articles/PMC8776163/
Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons
https://pubmed.ncbi.nlm.nih.gov/25915740/